|
View: |
Part 1: Document Description
|
|
Citation |
|
|---|---|
|
Title: |
5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA |
|
Identification Number: |
doi:10.7910/DVN/N1OGBY |
|
Distributor: |
Harvard Dataverse |
|
Date of Distribution: |
2025-03-11 |
|
Version: |
1 |
|
Bibliographic Citation: |
PCD, Thermo, 2025, "5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA", https://doi.org/10.7910/DVN/N1OGBY, Harvard Dataverse, V1 |
|
Citation |
|
|
Title: |
5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA |
|
Identification Number: |
doi:10.7910/DVN/N1OGBY |
|
Authoring Entity: |
PCD, Thermo (Chonnam National University) |
|
Distributor: |
Harvard Dataverse |
|
Access Authority: |
PCD, Thermo |
|
Depositor: |
PCD, Thermo |
|
Date of Deposit: |
2025-03-11 |
|
Holdings Information: |
https://doi.org/10.7910/DVN/N1OGBY |
|
Study Scope |
|
|
Keywords: |
Computer and Information Science, PD-L1, durvalumab |
|
Abstract: |
5X8M, anti-PD-L1 antibody, Durvalumab (311.5K, 38.5C, 500 ns), random seed #1: RMSD, RMSF, Rg, SASA. PDBs obtained every 50 ns. |
|
Methodology and Processing |
|
|
Sources Statement |
|
|
Data Access |
|
|
Other Study Description Materials |
|